Caleb K. Stein
Impact in
-
- Multiple Myeloma Research and Treatments
-
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
-
- Protein Degradation and Inhibitors 6
- Glycosylation and Glycoproteins Research 1
- PI3K/AKT/mTOR signaling in cancer 1
-
- Multiple Myeloma Research and Treatments 7
- Co-authors
- Erin W. Meermeier (6 shared papers)Meaghen E. Sharik (7 shared papers)P. Leif Bergsagel (7 shared papers)Marta Chesi (5 shared papers)Seth J. Welsh (3 shared papers)Daniel L. Riggs (3 shared papers)Victoria M. Garbitt (3 shared papers)Chang‐Xin Shi (1 shared paper)
- Journals
- Blood (5 papers)Haematologica (1 paper)Nature Communications (1 paper)Blood Cancer Discovery (2 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Caleb K. Stein
9 papers receiving 128 citations
Peers
Comparison fields: 5 of 24
- Hematology 62
- Oncology 67
- Radiology, Nuclear Medicine and Imaging 41
- Immunology 32
- Physiology 4
Countries citing papers authored by Caleb K. Stein
This map shows the geographic impact of Caleb K. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caleb K. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caleb K. Stein more than expected).
Fields of papers citing papers by Caleb K. Stein
This network shows the impact of papers produced by Caleb K. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caleb K. Stein. The network helps show where Caleb K. Stein may publish in the future.
Co-authors
The 25 scholars most cited alongside Caleb K. Stein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 67 | |
| 2 | 2019 | 24 | |
| 3 | 2020 | 20 | |
| 4 | 2019 | 5 | |
| 5 | 2017 | 5 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 1 | |
| 8 | 2021 | 1 | |
| 9 | 2022 | 1 |
About Caleb K. Stein
Caleb K. Stein is a scholar working on Molecular Biology, Hematology, Radiology, Nuclear Medicine and Imaging, Oncology and Immunology, having authored 9 papers that have together received 128 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (6 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), CAR-T cell therapy research (1 paper), Biosimilars and Bioanalytical Methods (1 paper), Glycosylation and Glycoproteins Research (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper) and Complement system in diseases (1 paper). The work is most often cited by research in Hematology (62 citations), Oncology (67 citations), Radiology, Nuclear Medicine and Imaging (41 citations), Immunology (32 citations) and Physiology (4 citations). Caleb K. Stein has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Erin W. Meermeier, Meaghen E. Sharik, P. Leif Bergsagel, Marta Chesi, Seth J. Welsh, Daniel L. Riggs, Victoria M. Garbitt, Chang‐Xin Shi, Matthew L. Wheeler and Pavel Strop. Their work appears in journals such as Blood, Haematologica, Nature Communications and Blood Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.